Ciontech Medical: Shareholder Anyang Qixu plans to reduce its company's shares by no more than 3%.

Xingy ylio gnggo chng, gdng nyng q x chyu gngs 860.23 wn g, zhn zng gbn 5.38%, gi bfn gfn y y 2024 nin 3 yu 31 r jijn. Yn zshn zjn xqi, q n zi 2026 nin 2 yu 4 r zh 5 yu 3 r, tnggu jzhng jngji, dzng jioy fngsh hj jinch b cho 480 wn g, j b cho zng gbn 3%, qzhng jzhng jngji b cho 160 wn g, dzng jioy b cho 320 wn g, jinch jig nsh chx, bnc jinch b hu dozh gngs kngzhqun bingng. Xiangyu Medical announced that shareholder Anyang Qixu holds 8.6023 million shares of the company, accounting for 5.38% of the total share capital. These shares were unlocked on March 31, 2024. Due to its own funding needs, it plans to reduce its holdings by a total of no more than 4.8 million shares from February 4 to May 3, 2026, through centralized bidding and block trading, i.e. no more than 3% of the total share capital, with centralized bidding not exceeding 1.6 million shares and block trading not exceeding 3.2 million shares. The selling price will be determined by the market price, and this reduction will not result in a change in the company's controlling interest.